What biomarkers can reliably detect microglial priming states in living patients before neurodegeneration?

biomarkers partially_addressed
Open a bounty challenge Fund this gap and accept submissions. SPEC-033.
Composite
—
Novelty
—
Mechanistic
—
Druggability
—
Priority
88%
Importance
—
Tractability
—
Market price
50%

Description

The debate focused on therapeutic targets but did not address how to identify patients in the optimal treatment window. Without reliable biomarkers for microglial priming, clinical translation of these hypotheses remains problematic.

Source: Debate session sess_SDA-2026-04-04-gap-20260404-microglial-priming-early-ad (Analysis: SDA-2026-04-04-gap-20260404-microglial-priming-early-ad)